Shivalik Rasayan signs marketing agreement with China Chinopharma; Stock climbs 2.5%

3 Aug 2022 , 10:23 AM

Shivalik Rasayan Ltd has informed to the exchanges that it has entered into a long term marketing agreement with China Chinopharma Limited (CSC) to supply DMF grade BUSALFAN, API.

As per the filing, the CSC shall hold Market Authorization (MA) to sell SRL’s BUSALFAN, API exclusively in China territory, the company said.

Notably, the CSC is a leader and pioneer who specializes in dealing with Pharmaceutical products having more than 20 years of experience.

At around 10:26 AM, Shivalik Rasayan was trading at Rs871.90 per share higher by 2.58% on the BSE.

Previously, the scrip ended at Rs850 per share on the BSE platform.